Kidney Cancer

RSS | Login | Register

Renal Cell Carinoma Type Tied to Time on Dialysis

Jody A. Charnow March 02, 2010

The histologic type of renal cell carcinoma (RCC) arising in patients with end-stage renal disease (ESRD) may be related to the time on dialysis, according to a study.

Excellent Short-Term Outcomes Reported for RAPN

Jody A. Charnow March 02, 2010

Robot-assisted partial nephrectomy (RAPN) is a safe and effective approach for nephron-sparing surgery (NSS) that is capable of providing patients with excellent short-term oncologic outcomes, according to the largest RAPN experience described to date.

Pre-Nephrectomy Sorafenib Shrinks Renal Cancer Tumors

John Schieszer February 25, 2010

Administering sorafenib prior to nephrectomy for renal cell carcinoma (RCC) can reduce the size of the primary tumor with adding to the risk of surgery, according to researchers at the University of North Carolina at Chapel Hill.

Renal Cancer Is More Likely in Obese Individuals

Delicia Honen Yard February 16, 2010

Obese individuals with kidney tumors are 48% more likely to develop a clear-cell renal cell carcinoma (RCC) than non-obese individuals, researchers reported in BJU International (2010;105:16-20).

Excellent Short-Term Outcomes Reported for Robot-Assisted Partial Nephrectomy

Jody A. Charnow January 27, 2010

Renal Cell Carcinoma with Capsular Invasion Predicts Worse Outcomes

Jody A. Charnow December 15, 2009

Renal capsular invasion in patients with localized clear-cell renal cell carcinoma (RCC) is associated with an increased risk of cancer recurrence and cancer-related death after surgery, according to researchers at the Catholic University of Korea in Seoul.

New Medication Approved for Treated Advanced Renal Cell Carcinoma

Jody A. Charnow November 19, 2009

The FDA has approved Votrient (pazopanib) for the treatment of advanced renal cell carcinomia (RCC).

Neoadjuvant VEGF-Targeted Therapy in Renal Cell Carcinoma

Steven Campbell, MD, PhD, Brian L. Rini, MD November 19, 2009

Recent therapeutic advances in metastatic renal cell carcinoma (RCC) have included agents targeted against vascular endothelial growth factor (VEGF).

TNM Staging System for Renal Cell Carcinoma Is Imprecise

Rosemary Frei, MSc October 23, 2009

The number and density of positive nodes provide more accurate survival predictions.

Wider Use of Radiofrequency Ablation Possible

Rosemary Frei, MSc October 16, 2009

Radiofrequency ablation of small renal tumors in otherwise healthy patients preserves renal function.

Enter a contest to win one of three $150 American Express gift cards by signing up for the free NKF Live e-newsletter. You will receive daily news coverage of the National Kidney Foundation 2010 Spring Clinical Meetings in Orlando, Fla.

Click here to sign up today

Visit Fresenius Medical Care during the National Kidney Foundation 2010 Spring Clinical Meetings in Orlando, Fla. at Booth #407.

Do you have a challenging case to share with colleagues?

If so, send us a brief description so that we can consider it for "Case of the Month," our online clinical quiz.
Click here to contact the editor.

Renal Masses

Excellent Short-Term Outcomes Reported for RAPN

Partial Nephrectomy for Larger Renal Masses

Less Bed Rest Is Safe After Renal Biopsy

Central Renal Masses More Likely to Be RCC

Expert Series I

Hyperphosphatemia in CKD

New Phosphate Binders on the Horizon

This article by Wajeh Y. Qunibi, MD, FACP of the University of Texas Health Sciences Center at San Antonio is the final in a series on managing hyperphosphatemia in CKD patients.
Part V: Neenoo Khosla, MD, and Stuart M. Sprague, DO
Part IV: Michal L. Melamed, MD, MHS
Part III: Kamyar Kalantar-Zadeh, MD, PhD, MPH
Part II: Joseph A. Coladonato, MD, MHS
Part I: Csaba P. Kovesdy, MD

Renal & Urology News
E-Newsletters

Sign up today to start receiving one of three free e-newsletters from Renal & Urology News or get them all.
- eTOC (print edition preview)
- RUN Roundup
- Conference Highlights

Sample | Subscribe | Archive